Alternatively, chemotherapy can upregulate the expression of costimulatory molecules (B7-1) or downregulate the expression of co-inhibitory molecules (PD-L1/B7-H1 or B7-H4) expressed on the tumor cell surface, enhancing the activity of effector T cells (Wargo et al., 2015). The gene discussed is CD274; the disease is neoplasm.